LAWRENCE, Mass., Jan. 20, 2015 /PRNewswire/
-- NxStage Medical, Inc. (Nasdaq: NXTM), a leading
manufacturer of innovative dialysis products, today announced the
creation of its annual Zenith Award to recognize acute renal care
teams for their outstanding contributions to patient care. The
award recipient will be announced on April
15, 2015 at a NxStage sponsored event during the 2015 AACN
National Teaching Institute Critical Care Exposition in
San Diego, California.
Interested participants are encouraged to submit an application
for review by March 31, 2015 online
at www.nxstage.com/zenith. Applicants are asked to detail specific
examples of their creative, and effective, contributions to acute
renal therapy services.
"The ICU teams administering therapy to a patient with acute
kidney failure are critical to that patient's potential health and
well-being," said Joe Turk,
President of NxStage. "The Zenith Award is a much deserved
recognition for the teams that dedicate their lives to continuously
improving acute renal therapy with innovative solutions, and
ultimately bettering patient care."
NxStage has provided renal replacement therapy solutions to ICUs
for acute kidney injury since 2002. The NxStage® System
Onetm is used in 7 of the top 10 leading renal care
hospitals, as ranked by U.S. News and World Report.1 The
System One is designed to simplify the delivery of renal care,
while providing clinicians with the flexibility to individualize
therapy for their patients in the ICU.
About NxStage
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device
company, headquartered in Lawrence,
Massachusetts, USA, that develops, manufactures and markets
innovative products for the treatment of ESRD and acute kidney
failure. For more information on NxStage and its products, please
visit the Company's website at www.nxstage.com.
Forward-Looking Statements
This release contains "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995.
All statements contained in this release that are not clearly
historical in nature are forward-looking, and the words
"anticipate," "believe," "expect," "estimate," "plan," and similar
expressions are generally intended to identify forward-looking
statements. Actual results may differ materially from those
indicated by these forward-looking statements as a result of
various important factors including those that are discussed in
NxStage's filings with the Securities and Exchange Commission,
including the Quarterly Report on Form 10-Q for the quarter
ended September 30, 2014. NxStage is under no obligation to
(and expressly disclaims any such obligation to) update or alter
its forward-looking statements, whether as a result of new
information, future events or otherwise.
Reference: 1. U.S. News Best Hospitals Data: Nephrology.
2014-2015. Available at:
http://health.usnews.com/best-hospitals/rankings/nephrology
Contact:
Kristen Sheppard
ksheppard@nxstage.com
Logo -
http://photos.prnewswire.com/prnh/20110503/MM94799LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nxstage-establishes-annual-zenith-award-to-recognize-excellence-in-acute-renal-care-300022580.html
SOURCE NxStage Medical, Inc.